Trials / Unknown
UnknownNCT03839238
Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury
Safety Observation on Human Embryonic Stem Cell (hESC) Derived Mesenchymal Stem Cells(MSC) Like Cell for the Meniscus Injury
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
human embryonic stem cell derived mesenchymal stem cells like cell for the meniscus injury, and observe the safety of the cells for meniscus injury
Detailed description
Three different dosage of human embryonic stem cell derived mesenchymal stem cells like for meniscus injury patients, and observe the safety of the cells for meniscus injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | hESC derived MSC like cell | Different dosage of hESC derived MSC like cell for the meniscus injured patients |
Timeline
- Start date
- 2019-01-04
- Primary completion
- 2020-06-30
- Completion
- 2020-09-30
- First posted
- 2019-02-15
- Last updated
- 2019-02-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03839238. Inclusion in this directory is not an endorsement.